Maria Sunzel - Teva Pharmaceuticals
Custom1000231240export1628749740615 - 0812 14 29 00, PDF, Virtual Reality
Edward Hellriegel - Teva Pharmaceuticals
PDF) Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
PDF) Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis
Walid Awni email address & phone number Awni BioPharmaceutical Consulting, LLC contact information - RocketReach
Maria Sunzel - Teva Pharmaceuticals
Dose-Normalized Pharmacokinetic Parameters for the Active HTBZ
Maria Sunzel - Teva Pharmaceuticals
Maria Sunzel - Teva Pharmaceuticals
ProductCreationTemplate 2020-12-03 1
Edward Hellriegel - Teva Pharmaceuticals
Dose-Normalized Pharmacokinetic Parameters for the Active HTBZ
Maria SUNZEL, PhD